Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
CDC MMWR report reveals 44 cases of invasive Haemophilus influenzae type b disease in Alaska, Oregon, and Washington, predominantly affecting adults using substances or experiencing homelessness.
New JAMA study shows Medicaid expansion significantly increased access to buprenorphine for opioid use disorder, with Oklahoma seeing 43% drop in overdose deaths.
White House prepares executive order to fund research into ibogaine for PTSD and traumatic brain injury, potentially opening new avenues for addiction treatment research.
Federal funding cuts to SAMHSA grants put overdose prevention, naloxone distribution, and peer recovery programs at risk across the United States.
Grocery chain settlement brings Colorado's total opioid settlement recovery past $912 million as state continues negotiating injunctive relief terms with remaining defendants.
Agency will now require only one adequate clinical trial supported by confirmatory evidence, a change officials say reflects advances in biomedical science and could accelerate development of addiction treatments.
CDC data shows historic 37% decline in drug deaths since 2023 peak, but medetomidine, cychlorphine, and nitazenes threaten progress.
ONDCP, SAMHSA, and HUD launch two-day summit to develop national toolkit for treating substance use disorders among homeless populations.
Drug 5-10 times more potent than fentanyl detected in Georgia and Missouri, as new study reveals standard naloxone doses may be insufficient for reversing synthetic opioid overdoses.